Enterprise record

Prime Medicine, Inc.

Public governance Claims and source records for this enterprise.

Follow
More
Reports & analysis (Directory temporarily unavailable)Alpha EvalSave PDFCompareChallenge a ClaimClaim this record

Alpha ID: alpha:company:0f3da0f6-f82f-4909-8cec-cc5ac4d832bcVersion: public-1As of: unavailable

14 published Claims2 sources

Key Claims

Board and committees

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

No current membership is published in Alpha's tracked index universe.

This is not evidence that the company is absent from every market index.

As of Sep 28, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 28, 2026

    Supports 3 claims
    • Legal Name: Prime Medicine, Inc. · Claim reviewed: Sep 28, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 28, 2026
    • Published Fact: US · Claim reviewed: Sep 28, 2026

  2. SEC DEF 14A 0001628280-26-026697

    sec def 14a · Source published: Apr 23, 2026 · Retrieved: Sep 12, 2026

    Supports 11 claims
    • Leadership Role: Jeffrey D. Marrazzo: Executive Chair of the Board · Claim reviewed: Sep 28, 2026
    • Leadership Role: Allan Reine, M.D.: Chief Executive Officer and Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: David Schenkein, M.D.: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Kaye Foster: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Michael Kelly: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Robert Nelsen: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Thomas Cahill, M.D., Ph.D.: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Wendy Chung, M.D., Ph.D.: Director · Claim reviewed: Sep 28, 2026
    • Leadership Role: Allan Reine, M.D.: Chief Executive Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Ann Lee, Ph.D.: Chief Technical Officer · Claim reviewed: Sep 28, 2026
    • Leadership Role: Svetlana N. Makhni: Chief Financial Officer · Claim reviewed: Sep 28, 2026